# Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell Carcinoma

> **NCT01144169** · PHASE1 · TERMINATED · sponsor: **University of Pittsburgh** · enrollment: 7 (actual)

## Conditions studied

- Renal Cell Carcinoma

## Interventions

- **DRUG:** Hydroxychloroquine (HC)

## Key facts

- **NCT ID:** NCT01144169
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-10
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** barriers to accrual: delay until surgery and additional pre-operative visits
- **Last updated:** 2016-10-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01144169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01144169, "Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01144169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*